Renaissance Technologies
BIVV

Renaissance Technologies’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Renaissance Technologies’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-291,200
Closed -$15.7M – 3736
2017
Q4 		$15.7M Sell
291,200
-513,600
-64% -$28.1M 0.02% 1112
2017
Q3 		$45.9M Buy
+804,800
New +$47.1M 0.05% 460

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Renaissance Technologies's BIVV Position: Q1 2018 in Review

Renaissance Technologies sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 291,200 shares — an estimated $15.7M sold.

Renaissance Technologies first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $45.9M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Renaissance Technologies reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Renaissance Technologies sold 291,200 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $15.7M.
  • Renaissance Technologies first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Renaissance Technologies's Bioverativ Inc. Common Stock position peaked at $45.9M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.